COMMUNIQUÉS West-GlobeNewswire

Daré Announces Presentation of Two Posters at the 2019 Controlled Release Society Annual Meeting & Exposition
22/07/2019
DARE-HRT1 is a potential treatment of menopause-related symptoms DARE-FRT1 is a potential pregnancy maintenance therapy SAN DIEGO, July 22, 2019 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ:DARE), a leader in women [...]
Sun BioPharma, Inc. Provides an Update on Ongoing Front-line Pancreatic Cancer Clinical Trial
22/07/2019
Preliminary Efficacy Signals Seen with SBP-101 Administered in Combination with Gemcitabine and Nab-paclitaxel DSMB Approves Enrollment of 3 rd and Final Cohort MINNEAPOLIS, July 22, 2019 (GLOBE NEWSWIRE) -- Sun [...]
Share buy-back week 29/2019
22/07/2019
Announcement 22 July 2019 Coloplast – transactions in connection with share buy-back programme As mentioned in Announcement No. 2/2019 Coloplast has initiated the second part of the share buy-back programme totalling up [...]
Vystar Enters Definitive Agreement to Acquire Rotmans Furniture – Largest Independent Furniture Retailer in Northeast
22/07/2019
Rotmans Furniture expected to significantly increase Vystar revenue Provides Vystar with sales, warehousing and distribution infrastructure Enables Rotmans Furniture to access the capital markets for future growth and [...]
Global Cannabis Corp & Partner SLANG Worldwide Receive Greek Medical Cannabis Cultivation, Processing and Manufacturing License
22/07/2019
TORONTO and ATHENS, Greece, July 22, 2019 (GLOBE NEWSWIRE) -- Global Cannabis Corp. (“ GCC ” or the “ Company ”) and its partner SLANG Worldwide Inc. ( CNSX: SLNG ), (Frankfurt: 84S), (" SLANG ") are pleased to announce [...]
Apellis Pharmaceuticals Expands Leadership Team, Appoints Lucia Celona as Chief People Officer
22/07/2019
CRESTWOOD, Ky. and WALTHAM, Mass., July 22, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals, Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
Cyclacel Pharmaceuticals Announces First Patient Treated in a Phase 1/2 Study of Sapacitabine and Venetoclax in Relapsed or Refractory AML or MDS Patients
22/07/2019
BERKELEY HEIGHTS, N.J., July 22, 2019 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) ("Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on [...]
FibroGen Announces First Patient Dosed in ZEPHYRUS, a Phase 3 Clinical Trial of Pamrevlumab for the Treatment of Patients with Idiopathic Pulmonary Fibrosis
22/07/2019
SAN FRANCISCO, July 22, 2019 (GLOBE NEWSWIRE) -- FibroGen, Inc. (NASDAQ: FGEN), today announced dosing of the first patient in the ZEPHYRUS Phase 3 clinical study of pamrevlumab in patients with idiopathic pulmonary [...]
MediWound Launches EscharEx® U.S. Clinical Development Program
22/07/2019
Company’s primary focus turns to EscharEx following its successful collaboration for NexoBrid Company to initiate an adaptive comprehensive adequately controlled study in 4Q 2019 Company to host Analyst Day today, July [...]
Cara Therapeutics Announces No Modifications in Trial Size for Phase 2 Trial of Oral KORSUVA™ in Chronic Kidney Disease Patients with Pruritus after Completion of Interim Statistical Assessment
22/07/2019
- Study now fully enrolled; topline data expected in 4Q 2019 - STAMFORD, Conn., July 22, 2019 (GLOBE NEWSWIRE) -- Cara Therapeutics, Inc. (Nasdaq:CARA), a biopharmaceutical company focused on developing and [...]
Achillion’s ACH-5228 Achieves Positive Results in Phase 1 Multiple Ascending Dose Study in Healthy Volunteers
22/07/2019
ACH-5228 delivers near complete and sustained inhibition of the complement alternative pathway Twice-daily oral administration to move forward in Phase 2 trials Investigational New Drug (IND) application to be submitted [...]
HEXO’s dried flower and award-winning Elixir spray now available in Alberta
22/07/2019
GATINEAU, Quebec, July 22, 2019 (GLOBE NEWSWIRE) -- HEXO Corp (“HEXO” or the “Company”) (TSX: HEXO; NYSE: HEXO) cannabis products are now available to Alberta consumers for the first time after finalizing an agreement [...]
Les fleurs séchées et le spray primé Elixir de HEXO maintenant disponibles en Alberta
22/07/2019
GATINEAU, Québec, 22 juill. 2019 (GLOBE NEWSWIRE) -- Pour la première fois, les produits de cannabis de HEXO Corp (« HEXO » ou la « Société ») (TSX : HEXO; NYSE : HEXO) sont disponibles pour les consommateurs de l' [...]
Novo Nordisk A/S – Share repurchase programme
22/07/2019
Bagsværd, Denmark, 22 July 2019 – On 7 May 2019, Novo Nordisk initiated a share repurchase programme in accordance with Article 5 of Regulation No 596/2014 of the European Parliament and Council of 16 April 2014 (MAR) [...]
Transactions under Novozymes’ stock buyback program
22/07/2019
Please read the full announcement in the attached PDF Attachment 2019_24_Stock_Buybackprogram_EN
Adynxx Adds Gregory J. Flesher to Board of Directors, Completes Up-listing to OTCQB Market
22/07/2019
SAN FRANCISCO, July 22, 2019 (GLOBE NEWSWIRE) -- Adynxx, Inc. (OTCQB: ADYX), a clinical-stage biopharmaceutical company focused on the development of transcription factor decoy technology and first-in-class therapeutics [...]
Orion Corporation: Managers’ transactions – Timo Lappalainen
22/07/2019
ORION CORPORATION MANAGERS’ TRANSACTIONS 22 July 2019 at 10.45 EETS Orion Corporation: Managers’ transactions – Timo Lappalainen Orion Corporation has received the following disclosure under Market Abuse Regulation (EU [...]
Aino Health AB (publ): Aino Health Germany signs partnership agreement with 55BirchStreet
22/07/2019
Aino Health and 55BirchStreet, a German digital consulting company, have signed a partnership agreement. 55BirchStreet will sell licenses and implementation services for Aino’s health management platform HealthManager [...]
Saniona selects highly promising preclinical candidate with broad potential in autoimmune disorders
22/07/2019
PRESS RELEASE July 22, 2019 Preclinical candidate SAN903 to be developed to Phase 1 clinical study in 18 months First-in-class compound with a new mode-of-action and strong IP Saniona AB (OMX: SANION) today announces [...]

Pages